Srocef S 250mg/125mg Injection
Marketer
Shakam Lifesciences
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Srocef S 250mg/125mg Injection
Cefixime and Sulbactam 250mg/125mg injection is a dual-action antibiotic. It's used to combat a range of bacterial infections by inhibiting microbial proliferation and halting infection spread. Administration must be strictly under medical guidance. Complete the prescribed course, even with symptom improvement; premature cessation may compromise effectiveness. Potential side effects include nausea, vomiting, diarrhea, and digestive upset. Report any worsening symptoms to your physician. Seek urgent medical attention for allergic reactions (rash, itching, swelling, breathing difficulties). Inform your doctor about all current medications, especially if you are pregnant, breastfeeding, or have pre-existing conditions. Alcohol consumption should be avoided due to potential increased drowsiness. While it typically doesn't affect driving ability, refrain from driving if drowsiness or dizziness occurs. Adequate rest, a balanced diet, and hydration are crucial for recovery. Your doctor might order tests to monitor the medicine's impact.
Primary Ingredients of Srocef S 250mg/125mg Injection
No information provided. Please provide the text you wish me to rephrase.
Uses of Srocef S 250mg/125mg Injection
Infections caused by bacteria
Major Benefits of Srocef S 250mg/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Srocef S 250mg/125mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Srocef S 250mg/125mg Injection:
The medication will be administered by your physician or their associate; self-medication is strictly prohibited.
How Srocef S 250mg/125mg Injection works:
The injectable formulation Srocef S, containing 250mg Ceftriaxone and 125mg Sulbactam, unites a cephalosporin antibiotic with a beta-lactamase inhibitor. Ceftriaxone's antibacterial action stems from disrupting bacterial cell wall synthesis, crucial for their viability. Sulbactam's role is to counteract bacterial resistance mechanisms, thereby optimizing Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse interactions between Srocef S 250mg/125mg Injection and alcohol consumption.
PregnancySAFE IF PRESCRIBED
Cefuroxime axetil injection (250mg/125mg) is typically deemed safe for use during pregnancy. Preclinical trials in animals revealed minimal or absent harmful effects on fetal development; nevertheless, data from human studies are scarce.
Breast feedingCAUTION
Administering Srocef S 250mg/125mg Injection to breastfeeding mothers requires careful consideration. Mothers should temporarily discontinue breastfeeding throughout the course of treatment and until the medication is fully cleared from their system.
DrivingUNSAFE
The administration of Srocef S 250mg/125mg Injection can induce drowsiness, visual disturbances, and dizziness. Operation of a vehicle should be avoided if such effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Srocef S 250mg/125mg Injection to individuals with renal impairment. Physician consultation is recommended.
LiverCAUTION
Individuals with severe hepatic impairment should exercise caution when using Srocef S 250mg/125mg Injection, as dose modification may be necessary. Physician consultation is advised. Dosage alteration for Srocef S 250mg/125mg Injection is not suggested for those with mild to moderate liver dysfunction.
What if you forget to take Srocef S 250mg/125mg Injection :
Should you forget a dose of Srocef S 250mg/125mg Injection, seek medical advice.
Facts to Know About Srocef S 250mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Anti-infective agents |
3,018 People bought this recently